Participants received weekly injections of the highest tolerated doses of Zepbound, either 10 milligrams or 15 milligrams, or Wegovy, 1.7 milligrams or 2.4 milligrams. By the end of the trial ...

According to the Associated Press, trial participants received weekly injections of the highest tolerated doses of Zepbound, either 10 milligrams or 15 milligrams, or Wegovy, 1.7 milligrams or 2.4 ...

The Danish drugmaker unveiled a series of initiatives to increase access to Wegovy and clamp down on use of the knock-off ...

After 12 weeks, weight loss with the drug was 13% of body weight, compared to 1% with placebo, which the company said was around twice the level achieved with Wegovy ... in the STEP 9 trial.

came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial. This translated to an average loss of 50.3 lb (22.8 kg) with tirzepatide and 33.1 lb (15.0 ...

the GLP-1 drug sold as Wegovy for weight loss and administered as a once-weekly injection. In a major late-stage (phase 3) clinical trial, semaglutide successfully treated nearly 2 out of 3 people ...

Novo Nordisk said Friday that CEO Lars Fruergaard Jørgensen is stepping down as the Wegovy maker seeks to revive ... Novo Nordisk shares closed 1.8% lower Friday. Meanwhile, shares of rival ...